Minnesota bills · 2025-2026 Regular Session
Minnesota HF 4064
Commissioner of health directed to study and report on activities to support innovations in cell and gene therapy to treat rare diseases, report required, and money appropriated.
- Introduced
- In committee
- Passed House
- Passed Senate
- To Governor
- Became law
Sponsors
- Reyer (Democratic-Farmer-Labor)
Cosponsors (9)
- Hollins (Democratic-Farmer-Labor)
- Mahamoud (Democratic-Farmer-Labor)
- Virnig (Democratic-Farmer-Labor)
- Berg (Democratic-Farmer-Labor)
- Nadeau (Republican)
- Freiberg (Democratic-Farmer-Labor)
- Bierman (Democratic-Farmer-Labor)
- Backer (Republican)
- Torkelson (Republican)
Summary
No official summary is available for this bill.
Latest action(Apr 20, 2026): Author added Torkelson
Text versions
- Introduction· Mar 6, 2026
Roll-call votes
No recorded votes on this bill.
Actions
- Apr 20, 2026 · House
Author added Torkelson - Mar 9, 2026 · House
Introduction and first reading, referred to Health Finance and Policy